scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0959-8049(99)00224-5 |
P698 | PubMed publication ID | 10674001 |
P2093 | author name string | Thorgeirsson SS | |
Nagy P | |||
Schaff Z | |||
Sebestyén A | |||
Schnur J | |||
P2860 | cites work | Promotion mechanism of phenobarbital and partial hepatectomy in DENA hepatocarcinogenesis cell kinetics effect | Q28367495 |
Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions | Q34480115 | ||
Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion | Q36392971 | ||
Biochemical and molecular aspects of mammalian susceptibility to aflatoxin B1 carcinogenicity | Q40604974 | ||
Studies on progressive metabolic alterations in thioacetamide induced hepatocarcinogenesis | Q41433046 | ||
Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta | Q44225473 | ||
Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague-Dawley rats treated with tumorigenic doses of clofibrate | Q44524030 | ||
Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. | Q47852627 | ||
Effect of orotic acid on in vivo DNA synthesis in hepatocytes of normal rat liver and in hepatic foci/nodules. | Q53480763 | ||
Mutations in the Ha-ras proto-oncogene in spontaneous and chemically induced liver tumours of the CF1 mouse. | Q53504979 | ||
Role of TGF-beta in normal differentiation and oncogenesis in rat liver. | Q54365620 | ||
Localized production of TGF-β mRNA in tumour promoter-stimulated mouse epidermis | Q59068394 | ||
Transforming Growth Factor-Beta Receptors and Mannose 6-Phosphate/Insulin-Like Growth Factor-II Receptor Expression in Human Hepatocellular Carcinoma | Q71970379 | ||
Dose-related changes in the profile of ras mutations in chemically induced CD-1 mouse liver tumors | Q72280962 | ||
Lamellar fibrosis in the fibrolamellar variant of hepatocellular carcinoma: a role for transforming growth factor beta | Q73569252 | ||
Inhibition of in vivo rat liver regeneration by 2-acetylaminofluorene affects the regulation of cell cycle-related proteins | Q74310575 | ||
P433 | issue | 13 | |
P921 | main subject | overexpression | Q61643320 |
P304 | page(s) | 1842-1845 | |
P577 | publication date | 1999-12-01 | |
P1433 | published in | European Journal of Cancer | Q332260 |
P1476 | title | Chemical hepatocarcinogenesis in transgenic mice overexpressing mature TGF beta-1 in liver. | |
P478 | volume | 35 |
Q34136515 | Biology of transforming growth factor beta in hepatocarcinogenesis |
Q34455310 | Cytosolic phospholipase A2alpha and peroxisome proliferator-activated receptor gamma signaling pathway counteracts transforming growth factor beta-mediated inhibition of primary and transformed hepatocyte growth |
Q34345987 | Experimental models of hepatocellular carcinoma |
Q42875977 | Ginger ingredients inhibit the development of diethylnitrosoamine induced premalignant phenotype in rat chemical hepatocarcinogenesis model |
Q40200602 | Hepatic stellate cells as key target in liver fibrosis |
Q34398029 | Hepatitis viruses and hepatocarcinogenesis |
Q34534264 | Immunotherapy of hepatocellular carcinoma |
Q39586591 | Mechanisms of liver fibrosis associated with experimental Fasciola hepatica infection: roles of Fas2 proteinase and hepatic stellate cell activation. |
Q28272678 | Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges |
Q34136011 | Role of transforming growth factor beta in cancer |